MARKET

PASG

PASG

Passage Bio, Inc.
NASDAQ
4.440
-0.040
-0.89%
After Hours: 4.440 0 0.00% 16:10 08/21 EDT
OPEN
4.530
PREV CLOSE
4.480
HIGH
4.725
LOW
4.350
VOLUME
36.52K
TURNOVER
--
52 WEEK HIGH
20.00
52 WEEK LOW
3.290
MARKET CAP
14.29M
P/E (TTM)
-0.3924
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PASG last week (0810-0814)?
Weekly Report · 4d ago
TD Cowen Sticks to Their Hold Rating for Passage Bio (PASG)
TipRanks · 08/11 06:45
Passage Bio Q2 EPS $(2.44) Beats $(3.47) Estimate
Benzinga · 08/10 11:45
Weekly Report: what happened at PASG last week (0803-0807)?
Weekly Report · 08/10 09:43
Weekly Report: what happened at PASG last week (0727-0731)?
Weekly Report · 08/03 09:43
Weekly Report: what happened at PASG last week (0720-0724)?
Weekly Report · 07/27 09:46
Weekly Report: what happened at PASG last week (0713-0717)?
Weekly Report · 07/20 09:44
Weekly Report: what happened at PASG last week (0706-0710)?
Weekly Report · 07/13 09:45
More
About PASG
Passage Bio, Inc. is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Its lead clinical product candidate, PBFT02, seeks to elevate progranulin levels to enhance lysosomal function and slow disease progression across a variety of neurodegenerative diseases. PBFT02 utilizes an adeno-associated virus serotype 1, or AAV1, capsid to deliver a functional granulin gene, encoding progranulin (PGRN), to the brain via intra cisterna magna (ICM) administration. Its development programs consist of PBFT02 for the treatment of FTD-GRN, PBFT02 for the treatment of FTD-C9orf72 and amyotrophic lateral sclerosis, and PBFT02 for the treatment of Alzheimer’s disease. Its clinical product candidates include PBGM01, PBKR03 and PBML04. It also has a preclinical research program that explores multiple potential treatment targets for Huntington's disease.

Webull offers Passage Bio Inc stock information, including NASDAQ: PASG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PASG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PASG stock methods without spending real money on the virtual paper trading platform.